1-9 of 9
Richard F. Ambinder
Close
Sort by
Journal Articles

Allogeneic transplantation for Ph + acute lymphoblastic leukemia with posttransplantation cyclophosphamide

Clinical Trials & Observations
Jonathan A. Webster, Leo Luznik, Hua-Ling Tsai, Philip H. Imus, Amy E. DeZern, Keith W. Pratz, Mark J. Levis, Ivana Gojo, Margaret M. Showel, Gabrielle Prince, Javier Bolaños-Meade, Lukasz P. Gondek, Gabriel Ghiaur, W. Brian Dalton, Tania Jain, Ephraim J. Fuchs, Douglas E. Gladstone, Christian B. Gocke, Syed Abbas Ali, Carol Ann Huff, Ivan M. Borrello, Lode Swinnen, Nina Wagner-Johnston, Richard F. Ambinder, Richard J. Jones, B. Douglas Smith
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5078–5088.
https://doi.org/10.1182/bloodadvances.2020002945
Published: 2020
Includes: Supplemental data
Journal Articles

Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide

Clinical Trials & Observations
Amy E. DeZern, Marianna L. Zahurak, Heather J. Symons, Kenneth R. Cooke, Gary L. Rosner, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, Philip Imus, Ivan Borrello, Nina Wagner-Johnston, Richard F. Ambinder, Leo Luznik, Javier Bolaños-Meade, Ephraim J. Fuchs, Richard J. Jones, Robert A. Brodsky
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1770–1779.
https://doi.org/10.1182/bloodadvances.2020001729
Published: 2020
Includes: Supplemental data
Journal Articles

CpG methylation in cell-free Epstein-Barr virus DNA in patients with EBV-Hodgkin lymphoma

Meir Shamay, Jennifer A. Kanakry, John S. W. Low, Netanel A. Horowitz, Guy Journo, Anuj Ahuja, Yonatan Eran, Elinor Barzilai, Eldad J. Dann, Jennifer Stone, Wan Lu Woo, Wen-son Hsieh, Rena R. Xian, Richard F. Ambinder
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1624–1627.
https://doi.org/10.1182/bloodadvances.2020001511
Published: 2020
Journal Articles

Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70

Clinical Trials & Observations
Philip H. Imus, Hua-Ling Tsai, Leo Luznik, Ephraim J. Fuchs, Carol Ann Huff, Douglas E. Gladstone, Patrick Lowery, Richard F. Ambinder, Ivan M. Borrello, Lode J. Swinnen, Nina Wagner-Johnston, Christian B. Gocke, Syed Abbas Ali, F. Javier Bolaños-Meade, Ravi Varadhan, Richard J. Jones
Journal: Blood Advances
Blood Adv (2019) 3 (17): 2608–2616.
https://doi.org/10.1182/bloodadvances.2019000155
Published: 2019
Includes: Supplemental data
Journal Articles

Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas

Clinical Trials & Observations
Erin G. Reid, David Looney, Frank Maldarelli, Ariela Noy, David Henry, David Aboulafia, Juan Carlos Ramos, Joseph Sparano, Richard F. Ambinder, Jeannette Lee, Ethel Cesarman, Sara Yahyaei, Ronald Mitsuyasu, William Wachsman
Journal: Blood Advances
Blood Adv (2018) 2 (24): 3618–3626.
https://doi.org/10.1182/bloodadvances.2018022095
Published: 2018
Includes: Supplemental data
Journal Articles

Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide

Laura K. Schoch, Kenneth R. Cooke, Nina D. Wagner-Johnston, Ivana Gojo, Lode J. Swinnen, Philip Imus, Ephraim J. Fuchs, Mark Levis, Richard F. Ambinder, Richard J. Jones, Douglas E. Gladstone
Journal: Blood Advances
Blood Adv (2018) 2 (17): 2226–2229.
https://doi.org/10.1182/bloodadvances.2018019208
Published: 2018
Journal Articles

Th17 immune microenvironment in Epstein-Barr virus–negative Hodgkin lymphoma: implications for immunotherapy

Clinical Trials & Observations
Amy S. Duffield, Maria Libera Ascierto, Robert A. Anders, Janis M. Taube, Alan K. Meeker, Shuming Chen, Tracee L. McMiller, Neil A. Phillips, Haiying Xu, Aleksandra Ogurtsova, Alan E. Berger, Drew M. Pardoll, Suzanne L. Topalian, Richard F. Ambinder
Journal: Blood Advances
Blood Adv (2017) 1 (17): 1324–1334.
https://doi.org/10.1182/bloodadvances.2017007260
Published: 2017
Includes: Supplemental data
Journal Articles

Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphoma

Clinical Trials & Observations
Jennifer J. G. Welch, Cindy L. Schwartz, Meghan Higman, Lu Chen, Allen Buxton, Jennifer A. Kanakry, Samir B. Kahwash, Robert E. Hutchison, Debra L. Friedman, Richard F. Ambinder
Journal: Blood Advances
Blood Adv (2017) 1 (11): 681–684.
https://doi.org/10.1182/bloodadvances.2016002618
Published: 2017
Journal Articles

Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide

Clinical Trials & Observations
Yvette L. Kasamon, Richard F. Ambinder, Ephraim J. Fuchs, Marianna Zahurak, Gary L. Rosner, Javier Bolaños-Meade, Mark J. Levis, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, William H. Matsui, Ivan Borrello, Robert A. Brodsky, Richard J. Jones, Leo Luznik
Journal: Blood Advances
Blood Adv (2017) 1 (4): 288–292.
https://doi.org/10.1182/bloodadvances.2016002766
Published: 2017
Includes: Supplemental data